Non-Invasive Prenatal Testing (NIPT)
Safe, accurate, and reliable genetic screening from 9 weeks of pregnancy.
Within 9 Calendar Days
Turnaround Time
99.9% Accuracy
Reliable Results
From 9 Weeks
Early Testing
Free Pickup
Convenient Service
About NIPT
Non-Invasive Prenatal Testing (NIPT) analyses small fragments of foetal DNA circulating in the mother’s blood. It allows early detection of chromosomal abnormalities such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome), without the risks associated with invasive procedures. The test also screens for up to 93 microdeletion and microduplication syndromes.
NIPT is recommended from as early as 9 weeks of gestation, providing highly accurate and reliable results. It offers both patients and clinicians confidence in pregnancy management and decision-making.
Who Should Consider NIPT?
- Expectant mothers irrespective of age
- History of chromosomal conditions in the family
- Abnormal ultrasound or first-trimester screening results
- Assisted reproduction (IVF/ICSI) pregnancies
Benefits of NIPT
- Completely non-invasive and risk-free for the fetus
- High accuracy and early detection
- Simple maternal blood draw
- Comprehensive analysis and clear reporting